HER2-Positive Breast Cancer | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with HER2-Positive Breast Cancer — Part 1 of a 5-Part Series

published 1 week ago by Dr Neil Love

Featuring perspectives from Dr Karen A Gelmon, including the following topics: Management of Metastatic HER2-Positive Breast Cancer Introduction (0:00) Case: A woman in her late 60s with HER2-positive breast cancer with symptomatic brain metastases — Sulfi Ibrahim, MD (5:26) Case: A woman in her late 30s with de novo ER-positive, HER2-positive breast cancer with brain metastases — Kelly Yap, MD (9:04) Case: A woman in her early 70s with ER-positive, HER2-positive de novo metastatic breast cancer — Chris Prakash, MD (15:04) Beyond the Guidelines (20:54) Localized HER2-Positive Breast Cancer Case: A woman in her early 60s with localized weakly ER/PR-positive, HER2-positive breast cancer — Andrea Stebel, MD (37:00) Case: A woman in her mid-50s with localized HER2-positive, node-positive breast cancer — Estelamari Rodriguez, MD, MPH (47:28) Beyond the Guidelines (51:19) CME information and select publications

more episodes from Research To Practice | Oncology Videos